Aims: Lipopolysaccharide (LPS) induces oxidative stress and neuroinflammation both in vivo and in vitro. Here, we provided the first detailed description of the mechanism of melatonin neuroprotection against LPS-induced oxidative stress, acute neuroinflammation, and neurodegeneration in the hippocampal dentate gyrus (DG) region of the postnatal day 7 (PND7) rat brain. Methods: The neuroprotective effects of melatonin against LPSinduced neurotoxicity were analyzed using multiple research techniques, including Western blotting, immunofluorescence, and enzyme-linked immunosorbent assays (ELISAs) in PND7 rat brain homogenates and BV2 cell lysates in vitro. We also used EX527 to inhibit silent information regulator transcript-1 (SIRT1). Results: A single intraperitoneal (i.p) injection of LPS to PND7 rats significantly induced glial cell activation, acute neuroinflammation, reactive oxygen species (ROS) production and apoptotic neurodegeneration in hippocampal DG region after 4 h. However, the coadministration of melatonin significantly inhibited both LPS-induced acute neuroinflammation and apoptotic neurodegeneration and improved synaptic dysfunction in the hippocampal DG region of PND7 rats. Most importantly, melatonin stimulated the SIRT1/Nrf2 (nuclear factor-erythroid 2-related factor 2) signaling pathway to reduce LPS-induced ROS generation. The beneficial effects of melatonin were further confirmed in LPS-stimulated BV2 microglia cell lines in vitro using EX527 as an inhibitor of SIRT1. LPS-induced oxidative stress, Nrf2 inhibition, and neuroinflammation are SIRT1-dependent in BV2 microglia cell lines. Conclusion: These results demonstrated that melatonin treatment rescued the hippocampal DG region of PND7 rat brains against LPS-induced oxidative stress damage, acute neuroinflammation, and apoptotic neurodegeneration via SIRT1/Nrf2 signaling pathway activation.
Introduction
Endotoxemia is among the most critical clinical diseases and has a high death rate due to the difficulty of making an accurate prognosis. A component of the outer membrane of Gram-negative bacteria, lipopolysaccharide (LPS), has been categorized as an endotoxin as a result of its ability to elicit immune cells and produce several proinflammatory cytokines and chemokines, which damages various organs [1] . Recent studies have suggested that LPS induces the activation of microglia cells, thereby increasing neurotoxicity via the production of various proinflammatory and cytotoxic factors, including nuclear factor kappa B (NF-jB) and downstream mediators [2] [3] [4] .
The silent information regulator transcript-1 (SIRT1) is a nicotinamide adenine dinucleotide (NAD)-dependent nuclear histone deacetylase that is involved in the regulation of several processes, such as controlling calorie restriction by extending the lifespan, metabolism, senescence, apoptosis, inflammation, and deacetylating histones and nonhistone proteins [5] [6] [7] [8] . The deacetylation ability of SIRT1 inhibits the transactivational activity of NF-k B [8] . Several studies have demonstrated that SIRT1 reduces the level of oxidative stress and the extent of inflammation [9] [10] [11] [12] .
Nuclear factor-erythroid 2-related factor 2 (Nrf2) is a pleiotropic protein and an important antioxidant sensor, and the activation of this protein is crucial for cellular defense mechanisms. Once it is activated, Nrf2 translocates from the cytoplasm to the nucleus and interacts with the antioxidant defense system to mediate the transcription of target genes, such as hemeoxygenase 1 (HO-1). The transcription of these genes increases resistance to oxidative stress and displays protection against inflammation [13] .
Melatonin, which is produced in many organs, including the pineal gland, macrophages, monocytes, and lymphocytes, is a multifunctional hormone that exerts various biological activities, such as the reduction of oxidative stress, inflammation, and neurodegeneration [14] [15] [16] [17] [18] [19] [20] [21] . Melatonin is a strong antioxidant due to its free radical scavenging abilities and ability to reduce oxidative damage and inhibit neuroinflammation [14, 16, 18] in many models, including LPS [22] [23] [24] [25] . The neuroprotective effects of melatonin against LPS damage in adult rodents, neural stem cells, and neonatal rats have previously been reported [23, 26, 27] . This study was conducted to explore the detailed mechanism of action of melatonin against LPS-induced oxidative stress, acute neuroinflammation, and neurodegeneration in the hippocampal DG region of postnatal day 7 (PND7) rats. The results showed that melatonin stimulates the SIRT1/Nrf2 signaling pathway against LPS-induced oxidative stress in the DG region of the hippocampus of PND7 rats.
Materials and Methods

Animals and Drug Treatment
Postnatal day 7 (PND7) male pups from Sprague-Dawley rats (n = 5 animals/group) with an 18 g average body weight were randomly divided into four groups: (1) Control (C), (2) LPS, (3) LPS+Melatonin (LPS+Mel), and (4) Melatonin (Mel). The control animals received 0.1% DMSO and 0.9% saline solution, whereas the experimental groups received LPS (250 lg/kg) [28] and melatonin (10 mg/kg) [29] treatments, intraperitoneally (i.p.) administered as a single injection. Melatonin (dissolved in 0.1% DMSO and diluted with 0.9% saline solution) was coadministered after 30 min of LPS, and the animals were sacrificed at 4-12 h after injection. The local animal ethics committee of the Division of Applied Life Sciences, Department of Biology, Gyeongsang National University South Korea, approved all experimental procedures.
Chemicals
Melatonin, LPS, DCFDA, and EX527 were purchased from SigmaAldrich.
Cell Culturing and Drug Treatment
Murine BV2 microglia and mouse hippocampal neuronal HT22 cells were maintained on DMEM medium containing 10% FBS and 1% penicillin/streptomycin at 37°C in a humidified 5% CO 2 incubator. The cells were treated with LPS (1 lg/mL), LPS plus melatonin (1 lg/mL + 100 lM), LPS plus Ex527 (1 lg/mL + 20 lM), and LPS plus Ex527 plus melatonin (1 lg/mL + 20 lM + 100 lM) for 4 h.
Western Blot Analysis
The Western blot analysis was conducted as previously reported [30] . Briefly, the animals were sacrificed after four h following LPS administration with or without melatonin treatment. The brains (hippocampus) were carefully collected, and dry ice was used to freeze the tissue. Similarly, after treatment, the BV2 and HT22 cells were collected in phosphate buffer saline (PBS), centrifuged, and the supernatant was removed. The remaining pellet was dissolved in Pro-Prep protein extraction solution, according to the manufacturer's instructions (iNtRON BIOTECHNOLOGY) to generate cell lysates. The brain homogenates and cell lysates were quantified using Bio-Rad protein assay solution. The homogenates (20 lg protein) were fractionated using SDS-PAGE on 4-12% Bolt TM Mini Gels (Novex; Life Technologies, Kiryat Shmona, Israel). After transfer, the membranes were blocked in 5% skim milk (or BSA), incubated overnight at 4°C with primary antibodies, and crossreacting proteins were detected using ECL after reaction with horseradish peroxidase-conjugated secondary antibodies. The primary antibodies, including rabbit-derived anti-COX2, anti-PARP-1, anti-Nrf2, anti-iNOS, anti-synaptophysin (Syp), and anti-p-NF-kB, mouse-derived anti-b-actin, anti-PSD95, anti-GFAP, anti-Hemeoxygenase-1 (HO-1), and goat-derived anti-Iba-1, were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). We also used mouse-derived anti-SIRT1 from Cell Signaling Technology, Inc. and mouse-derived anti-8-Oxoguanosine (8-OxoG) from Millipore. After using membrane-derived secondary antibodies, ECL (Amersham Pharmacia Biotech, Uppsala, Sweden) detection reagent was used for visualization according to the manufacturer's instructions. The densitometry analysis of the bands was performed using Sigma Gel software (SPSS, Chicago, IL, USA). The density values were calculated in arbitrary units (A.U.) relative to the untreated control.
Tissue Collection and Sample Preparation
For the morphological study of brain tissue, the animals were sacrificed after 12 h of drug treatment. An equal number of animals were maintained in each group (n = 5/group), and transcardial perfusion with 4% ice-cold paraformaldehyde and PBS was performed. After postfixing in 4% paraformaldehyde overnight, the samples were transferred to 20% sucrose solution until the brains sank to the bottom of the tube. Prior to obtaining 16-lm sections in the coronal planes using a Leica cryostat (CM 3050C; Germany), the brains were frozen in optimum cutting temperature (O.C.T) compound (A.O. USA). The sections were thawed and mounted on probe-on plus charged slides (Fisher).
Fluoro-Jade B Staining
Fluoro-Jade B staining was performed as previously described [31] . Brain tissue slides were air-dried overnight. Initially, the slides were immersed in a solution of 1% sodium hydroxide and 80% ethanol for 5 min, followed by 70% alcohol for 2 min and distilled water for 2 min. The slides were transferred to a 0.06% potassium permanganate solution for 10 min and subsequently rinsed with distilled water. Next, the slides were immersed in a 0.1% acetic acid and 0.01% Fluoro-jade B solution of for 20 min, rinsed with distilled water, and dried for 10 min. Glass cover slips were mounted onto the glass slides using mounting medium. The images were captured using an FITC filter on a confocal laser scanning microscope (FluoView FV 1000; Olympus, Tokyo, Japan).
Immunofluorescence
Immunofluorescence staining was performed as previously described [32, 33] . Briefly, tissue-containing slides and chamber slides were washed twice for 15 min in 0.01 M PBS, and subsequently, Proteinase K solution was added to the tissue and incubated for 5 min at 37°C. After blocking the brain tissues with normal goat serum, the primary antibodies Iba-1, Nrf2, 8-OxoG, and GFAP (1:100 in PBS) were applied, and the slides were incubated at 4°C overnight. The next day, secondary antibodies (FITC, Santa Cruz, 1:50 in PBS) were applied at room temperature for 90 min. The slides were washed twice with PBS for 5 min. DAPI (4 0 , 6-diamidino-2-phenylindole) was applied to stain the nuclei, and glass cover slips were mounted onto the glass slides using mounting medium. The images were captured using a confocal microscope (FluoView FV 1000).
Oxidative Stress (ROS) Detection In Vivo and In Vitro
To measure the ROS content in the brain homogenates of all experimental groups, we followed a recently published protocol [34] . Briefly, the brain homogenates were diluted with ice-cold Locke's buffer at 1:20 ratio, and after adding DCFH-DA (5 mM), this mixture was incubated at room temperature for 45 min for the conversion of DCFH-DA to DCF. Excitation was measured at 484 nm, and emission was measured at 530 nm. The ROS content was expressed as pmol DCF formed/min/mg protein.
The in vitro ROS assay was conducted using BV2 microglia cells as previously described [35] . Briefly, the cells were cultured in 96-well plates containing 200 lL DMEM medium supplemented with 10% FBS and 1% penicillin/streptomycin in each well. After incubation for 24 h at 37°C in a humidified 5% CO 2 incubator, the cells were treated with LPS (1 lg/mL), LPS plus melatonin (1 lg/ mL + 100 lM), LPS plus Ex527 (1 lg/mL + 20 lM), and LPS plus Ex527 plus melatonin (1 lg/mL + 20 lM + 100 lM) for 4 h. Subsequently, 600 lM DCFDA (2 0 , 7 0 -dichloroflourescin diacetate) dissolved in DMSO/PBS was added to each well, followed by incubation for 30 min. The plates were read on an ApoToxGlo TM (Promega Corp., Madison, WI, USA) at 488/530 nm.
Enzyme Assays
The hippocampi rat brain homogenates and BV2 cell lysates of the experimental groups were evaluated for different ELISA assays, such as Total NF-kB p65 ELISA (Invitrogen Corporation, Carlsbad, CA, USA; Catalog #KHO0371) SIRT1 HDAC Fluorimetric Assay kit (Promega Corp., Madison, WI, USA), and COX2 (R&D Systems, Inc., Minneapolis, MN, USA), performed according to the manufacturer's instructions.
Data and Statistical Analysis
The original X-ray films from the Western blot analyses were scanned and analyzed through densitometry using the computerbased Sigma Gel System (SPSS Inc., Chicago, IL). The density values were expressed as the means AE SEM. The ImageJ program was used to analyze the integral optical density (IOD). One-way analysis of variance (ANOVA) was used determine the significant difference, followed by Student's t-test. P values less than 0.05 (P < 0.05) were considered significant.
Results
Melatonin Ameliorated LPS-Induced Glial Cells Activation, their Associated Neuroinflammation and Synaptotoxicity in Developing Rat Brain
We first determined whether a single injection of LPS to PND7 rat pups activates glial cells, including microglia, and astrocytes, using an immunofluorescence technique. The results indicated that a single injection of LPS significantly induced the activation of astrocytes (GFAP) and microglia (Iba-1) in PND7 rat pups brain, as shown in Figure 1A and 1B. Furthermore, LPS also activated proinflammatory markers, including phosphorylated nuclear factor kappa (p-NF-jB), cyclooxygenase-2 (COX-2), and intrinsic nitric oxide synthetase (iNOS), after 4 h in PND7 rat brains (Figure 2A) . Conversely, the coadministration of melatonin not only significantly inhibited LPS-induced activated astrocytes and microglia but also significantly reversed the increased expression level of different proinflammatory markers, such as p-NF-jB, COX 2, and iNOS, as shown in Figure 2A . Additionally, melatonin treatment reduced the LPS-activated total NF-k Bp65 activity, as measured using an ELISA kit ( Figure 2B ). Furthermore, the beneficial effects of melatonin against LPS-induced synaptotoxicity were evaluated after 4 h in the PND7 rat brains. The immunoblot analysis revealed that melatonin markedly increased the expression of LPS-suppressed pre-and postsynapse-related proteins. The synapse-related proteins primarily comprised presynapse markerlike synaptophysin (Syp) and postsynapse density protein 95 (PSD95), as shown in Figure 2C .
Melatonin Reduced LPS-Induced Oxidative Stress in the Developing Brain
LPS induces oxidative stress by generating reactive oxygen species (ROS). To investigate whether melatonin inhibits ROS generation in the developing brain, ROS assays and immunohistopathologically 8-Oxoguanin (8-OxoG) staining were conducted. The results of the ROS assay indicated that at 4 h after administering LPS to young rats, significantly increased ROS production in the PND7 brain homogenates was observed compared with the saline-treated control ( Figure 3A) . However, the brain homogenates of the animals receiving melatonin through either alone or cotreated with LPS displayed reduced ROS production ( Figure 3A) . Additionally, the immunofluorescence images revealed that compared with the control animals, LPS significantly increased the immunofluorescence reactivity of 8-OxoG in the DG region of the PND7 rat brain. Similarly, the administration of melatonin to young rats significantly reduced the expression of 8-OxoG in the DG region of PND7 rat brains ( Figure 3B ).
Melatonin Abrogated LPS-Induced Apoptotic Neurodegeneration in the Developing Brain
A single injection of LPS in PND7 rat brains was further investigated for the induction of caspase-3 and PARP-1 as apoptosis and neurodegeneration markers. The immunoblot results reveal that LPS-treated young rats shown a significantly high expression of caspase-3 and PARP-1 proteins. However, the cotreatment of melatonin significantly reduced the expression levels of caspase-3 and PARP-1 in the PND7 rat brains ( Figure 3C ). Additionally, to determine the extent of neurodegeneration induced through LPS in the PND7 rat brains, Flouro Jade B (FJB) staining was performed. The images indicated that LPS induced widespread neurodegeneration in the DG region of the hippocampus of PND7 rat brains. In contrast to LPS treatment alone, the rat pups cotreated with melatonin and LPS showed markedly low numbers of FJBpositive neurons in the hippocampal DG region ( Figure 3D ).
Melatonin-Stimulated SIRT1/Nrf2 Signaling Pathway against LPS-Induced Oxidative Stress in the Developing Brain
To characterize the expression and activity of SIRT1, the brain homogenates of all treated young rats were subjected to Western blotting and SIRT1 activity assays. The results revealed that LPS significantly inhibited SIRT1 protein expression ( Figure 4A ) and activity ( Figure 4B ) compared with the saline-treated control. In contrast, melatonin treatment rescued the developing brain by significantly (P < 0.001) activating SIRT1 protein expression and activity ( Figure 4A,B) .
To analyze the antioxidant effect of melatonin, we measured the protein expression of Nrf2 and its downstream signaling gene hemeoxygenase-1 (HO-1). As shown in Figure 4A , LPS administration was significantly suppressed, and melatonin treatment markedly increased the expression of Nrf2 and HO-1 proteins in the developing brain. The immunohistological investigation of Nrf2 also supported the Western blot results, indicating that melatonin treatment increased the expression of Nrf2 in the hippocampal DG region of the developing rat brain (Figure 4A,C) . 
The Beneficial Effects of Melatonin against LPSInduced Oxidative Stress in BV2 Cells In Vitro
Glial cells, particularly microglia, are well-known LPS-responsive cells in the CNS. To elucidate the antiinflammatory and antioxidative role of melatonin against LPS-induced neuroinflammation and oxidative stress, BV2 microglial cells were used in vitro. The double immunofluorescence results ( Figure 5A ) revealed that LPS treatment not only stimulated BV2 microglial cells but also inhibited SIRT1 after 4 h compared with untreated BV2 cells in vitro. However, melatonin treatment significantly inhibited BV2 cell stimulation in vitro ( Figure 5A ). Additionally, melatonin also significantly induced the activation of SIRT1 against BV2 cells treated with LPS alone in vitro ( Figure 5A ). Similarly, melatonin treatment significantly induced Nrf2 activation and translocation into the nucleus compared with LPS-treated BV2 cells in vitro (Figure 5B) . Additionally, melatonin treatment reduced LPS-induced oxidative stress by reducing the expression of 8-OxoG in vitro (Figure 6A) .
To determine the mechanism of melatonin against LPS-induced oxidative stress in vitro, BV2 microglial cells were treated with LPS and melatonin and with or without SIRT1 inhibitor, that is, EX527, for 4 h, and the reactive oxygen species (ROS) production was analyzed using an ROS assay. The results ( Figure 6B) showed that melatonin significantly reduced LPS-induced ROS production in vitro. Interestingly, when SIRT1 was blocked with the inhibitor EX527, the LPS-induced ROS was further increased, and the ability of melatonin to reduce ROS production was abolished. This finding suggests that the ability of melatonin to reduce LPSinduced ROS is SIRT1 dependent ( Figure 6B ). 
Melatonin Activation of Nrf2 is SIT1 Dependent in BV2 Cells In Vitro
Melatonin stimulated the SIRT1/Nrf2 pathway to reduce LPSinduced oxidative stress. Thus, we investigated the SIRT1/Nrf2 signaling pathway through Western blot analysis in BV2 cells after inhibiting SIRT1 using the inhibitor EX527. The results indicated that melatonin significantly activated SIRT1 and Nrf2 protein expression and reduced caspase-3 expression against LPS in BV2 cells. However, in the presence of SIRT1 inhibitor, LPS not only further suppressed SIRT1 and Nrf2 expressions but also increased the caspase-3 protein levels in BV2 cells. However, EX527 also slightly affected the ability of melatonin to significantly inhibit caspase-3 and activate both SIRT1 and Nrf2 proteins as shown in Figure 7A . Similarly, the histogram of the results of the SIRT1 activity assay also support the Western blot results, showing that LPS significantly inhibits SIRT1 and melatonin, thereby increasing SIRT1 activity ( Figure 7B ).
Melatonin Inhibited LPS-Upregulated NF-j B and COX2 Protein in SIT1-Dependent Manner in BV2 Cells In Vitro NF-j B activation is considered the main event in the progression of the proinflammatory signaling pathway. Melatonin administration reduces NF-jB and the regulation of its downstream signaling molecules in the developing brain. To analyze whether the melatonin-mediated deactivation of the NF-jB signaling pathway is SIRT1-dependent, we used the SIRT1 inhibitor EX527 in BV2 cells, followed by Western blot analysis. The immunoblot results indicated that melatonin treatment reduced LPS-induced NF-jB and COX2 expression, whereas SIRT1 inhibition further upregulated NF-jB and COX2 expression ( Figure 8A ). In addition, melatonin significantly downregulated the expression of both NF-jB and COX2 proteins ( Figure 8A ). Similarly, we also conducted ELISA assays for both NF-jB and COX2 proteins in BV2 and HT22 cells. The results also showed that the LPS-induced activation of NF-jB and COX2 protein expression is SIRT1 dependent and that melatonin significantly decreased the expression of these proteins in both cell lines ( Figure 8B,C) .
Discussion
The present study contributes to research efforts to identify therapeutic agents to treat neurodegenerative diseases. LPS-induced neuroinflammation plays a crucial role in the progression of neurological disorders. The present study was designed to evaluate the neuroprotective potential of melatonin against oxidative stress and associated acute neuroinflammation by LPS in the hippocampal DG region of postnatal day 7 rat brains. This mechanistic report provides the first evidence that melatonin abrogates LPS-induced oxidative stress and acute neuroinflammation in an SIRT1-/Nrf2-dependent manner in the developing rat brain ( Figure 9 ). LPS is a toxic agent that generates ROS, which subsequently induces inflammation [36] [37] [38] . The LPS-generated ROS then activates NF-jB and increases iNOS and COX-2 at both the mRNA and protein level. Previous studies have reported the translocation of NF-jB to the nucleus in acute neuroinflammation, where this protein binds to DNA and activates the expression of proinflammatory genes, such as iNOS and COX-2 [39] . Similar studies have suggested that LPS induces ROS, which activates and translocates NF-jB and increases the proteins levels of iNOS and COX-2 [40] . Thus, we conducted the current study to determine the mechanism of LPS-induced oxidative stress and acute neuroinflammation in the developing rat brain. The results demonstrated that a single injection of LPS at day 7 into rat pups triggers ROS and acute neuroinflammatory responses in the hippocampal DG region of immature rat brains. In addition, this LPS dose is sufficient to induce the activation of glial cells, including microglia and astrocytes. Most importantly, LPS significantly inhibited the expression of SIRT1 and the endogenous antioxidant response system, that is, Nrf2 and HO-1 proteins, in rat pup brains. Several previously published studies have shown that melatonin reduces ROS production against different toxins in vitro and in vivo animal models [41] [42] [43] [44] [45] [46] [47] [48] . Thus, we also examined the therapeutic efficacy of melatonin in postnatal day 7 rat brains against LPS-induced oxidative stress and acute neuroinflammation. The results demonstrated that melatonin is potentially effective against LPS shock because melatonin reduced glial cell activation in the developing brain. Specifically, melatonin administration to PND7 rats activated Nrf2/HO-1 signaling proteins, as an endogenous antioxidant system, in an SIRT1-dependent manner to rescue the immature brain against LPS-induced oxidative stress and acute neuroinflammation. In this regard, recent findings have revealed that melatonin treatment could significantly up-regulate LPS-suppressed Nrf2 and HO1 protein levels [49] . Nrf2 is an important agent in the induction of various antioxidants, which regulates the cellular antioxidant response against ROS. Under normal conditions, Nrf2 exists in the cytoplasm, but in the presence of oxidative stress, Nrf2 translocates to the nucleus, where this protein can activate antioxidant responses by up-regulating several antioxidant enzymes, particularly HO-1, and decreasing the sensitivity to oxidative stress damage [50] . Additionally, Nrf2 plays an important role in modulating acute inflammatory responses [51] .
In the present study, we demonstrated that melatonin is responsible for the antiinflammatory activities in the immature rat brain and in BV2 cells. Most importantly, these results showed that melatonin completely inhibited LPS-induced glial cell activation, including both microglia and astrocytes, and the associated acute neuroinflammation. It has previously been demonstrated that melatonin, via the melatonin receptor, confers protection against the damage of developing white matter to inhibit microglial activation and oligodendroglial maturation [52] . Similarly, numerous studies have reported that melatonin reduces pro-inflammatory cytokine production and might inhibit the expression of proinflammatory enzymes, such as iNOS and COX-2, against LPS in vitro and in vivo [53] [54] [55] [56] .
In the present study, we hypothesized that melatonin exerts antioxidative and antiinflammatory activities via the activation of the SIRT1-dependent transcription factor Nrf2 in the immature rat brain and in BV2 cells. The protein expression, as measured by Western blot and ELISA, demonstrated that SIRT1 plays an important role in melatonin antioxidative and antiinflammatory effects. Consistent with the results from protein expression, when SIRT1 was inhibited with its inhibitor, the protein expression of SIRT1 and Nrf2 was significantly decreased in BV2 cells, suggesting that the LPS-induced inhibition of Nrf2 is SIRT1-dependent in vitro and in the developing rat brain. Similarly, these results showed that as a result of SIRT1 inhibition, the expression of proinflammatory proteins, such as p-NF-jB and COX-2, was further increased, suggesting that SIRT1 plays a significant role in LPS-induced neuroinflammation.
There are several explanations for the efficacy of melatonin as anti-ROS agent, including its potential inhibitory effects on lipid peroxidation; melatonin also exhibits stabilizer activity and acts as a protector of cell and organelle membranes [57] . Additionally, melatonin regulates various enzymes that play crucial roles in ROS production [58] . Similarly, melatonin reduces nitrite/nitrate production by reducing iNOS expression via NF-jB inhibition, which is activated by LPS. Moreover, melatonin can cross morphophysiological barriers and enter subcellular compartments because of its solubility in lipid and aqueous media, thus making melatonin a good antioxidant agent.
Taken together, these findings highlight melatonin as a potential therapeutic candidate for the treatment of oxidative stress, acute neuroinflammation, and associated neurodegeneration against LPS shock during development. Melatonin is an agent with low or even no side effects and is safe when used under multiple physiological conditions. Studies concerning melatonin protection against various toxins and the availability of this compound as a medicine under different physiological conditions suggest it poses no threat to human health. This study suggests a new strategy to target SIRT1/Nrf2 signaling pathway for the inhibition of LPS-induced neurodegenerative disorders. However, further studies will be needed to evaluate the mechanism of the role of melatonin in neurodegenerative diseases. Figure 9 Schematic diagram suggested a neuroprotective mechanism for melatonin against LPS-induced ROS, acute neuroinflammation, and neurodegeneration. The diagram depicts a potential mechanism by which melatonin prevents LPS-induced oxidative stress, acute neuroinflammation, and neurodegeneration via a SIRT1/Nrf2 signaling pathway in the hippocampal dentate gyrus region of PND7 rat brains. 
